S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.30%) $2 349.60
Silver
(-0.47%) $27.23
Platinum
(0.41%) $924.25
USD/EUR
(0.32%) $0.935
USD/NOK
(0.80%) $11.04
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.32%) $91.87

Realtime updates for Neogenomics Inc [NEO]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-04-30)

Expected move: +/- 10.97%

BUY
50.00%
return -0.35%
SELL
75.00%
return -5.21%
Last Updated26 Apr 2024 @ 16:00

2.09% $ 14.14

SELL 104022 min ago

@ $14.92

Issued: 14 Feb 2024 @ 15:55


Return: -5.23%


Previous signal: Feb 14 - 14:11


Previous signal: Buy


Return: 1.53 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments...

Stats
Today's Volume 787 712
Average Volume 905 165
Market Cap 1.81B
EPS $0 ( 2024-02-20 )
Next earnings date ( $-0.0300 ) 2024-04-30
Last Dividend $0.400 ( 2020-12-17 )
Next Dividend $0 ( N/A )
P/E -20.20
ATR14 $0.0180 (0.13%)
Insider Trading
Date Person Action Amount type
2024-03-04 Tetrault Lynn A. Sell 6 112 Common Stock
2024-02-23 Stone Warren Buy 42 344 Stock Option (Right to Buy)
2024-02-23 Stone Warren Buy 25 330 Performance Stock Unit
2024-02-23 Stone Warren Buy 25 329 Restricted Stock Unit
2024-02-23 Olivo Alicia C Buy 42 344 Stock Option (Right to Buy)
INSIDER POWER
92.16
Last 88 transactions
Buy: 4 083 000 | Sell: 279 791

Volume Correlation

Long: -0.40 (neutral)
Short: -0.78 (moderate negative)
Signal:(30.143) Neutral

Neogenomics Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neogenomics Inc Correlation - Currency/Commodity

The country flag -0.77
( moderate negative )
The country flag -0.73
( moderate negative )
The country flag 0.00
( neutral )
The country flag -0.19
( neutral )
The country flag 0.05
( neutral )
The country flag 0.01
( neutral )

Neogenomics Inc Financials

Annual 2023
Revenue: $591.64M
Gross Profit: $244.60M (41.34 %)
EPS: $-0.700
FY 2023
Revenue: $591.64M
Gross Profit: $244.60M (41.34 %)
EPS: $-0.700
FY 2022
Revenue: $509.73M
Gross Profit: $187.90M (36.86 %)
EPS: $-1.160
FY 2021
Revenue: $484.33M
Gross Profit: $187.06M (38.62 %)
EPS: $-0.0700

Financial Reports:

No articles found.

Neogenomics Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Neogenomics Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 3.17 - low (5.73%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.400 2020-12-17
Last Dividend $0.400 2020-12-17
Next Dividend $0 N/A
Payout Date 2020-12-30
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.400 --
Avg. Dividend % Per Year 0.09% --
Score 0.32 --
Div. Sustainability Score 3.17
Div.Growth Potential Score 0
Div. Directional Score 0.927 --
Next Divdend (Est)
(2024-04-27)
$0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
0.32
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2020 $0.400 1.38%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.1491.500-2.97-4.46[0 - 0.5]
returnOnAssetsTTM-0.05231.200-1.744-2.09[0 - 0.3]
returnOnEquityTTM-0.09211.500-2.13-3.20[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM6.200.80010.008.00[1 - 3]
quickRatioTTM5.670.80010.008.00[0.8 - 2.5]
cashRatioTTM3.561.50010.0010.00[0.2 - 2]
debtRatioTTM0.364-1.5003.94-5.90[0 - 0.6]
interestCoverageTTM20.011.0003.703.70[3 - 30]
operatingCashFlowPerShareTTM-0.01552.00-0.00517-0.0103[0 - 30]
freeCashFlowPerShareTTM-0.2442.00-0.122-0.244[0 - 20]
debtEquityRatioTTM0.650-1.5007.40-10.00[0 - 2.5]
grossProfitMarginTTM0.4131.0006.446.44[0.2 - 0.8]
operatingProfitMarginTTM-0.1741.000-5.48-5.48[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.003191.000-1.129-1.129[0.2 - 2]
assetTurnoverTTM0.3520.800-0.987-0.790[0.5 - 2]
Total Score3.17

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-19.831.000-2.100[1 - 100]
returnOnEquityTTM-0.09212.50-1.372-3.20[0.1 - 1.5]
freeCashFlowPerShareTTM-0.2442.00-0.0813-0.244[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.01552.00-0.00517-0.0103[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.009441.500-3.270[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.003301.000-2.580[0.1 - 0.5]
Total Score-1.320

Neogenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators